Scinovex
review Open AccessTop 1% cited

High Blood Pressure and Cardiovascular Disease

Hypertension · 2019 · Vol. 75(2) · pp. 285–292
Flávio Danni FuchsPaul K. Whelton

Abstract

Fragmented investigation has masked the overall picture for causes of cardiovascular disease (CVD). Among the risk factors for CVD, high blood pressure (BP) is associated with the strongest evidence for causation and it has a high prevalence of exposure. Biologically, normal levels of BP are considerably lower than what has typically been characterized as normal in research and clinical practice. We propose that CVD is primarily caused by a right-sided shift in the population distribution of BP. Our view that BP is the predominant risk factor for CVD is based on conceptual postulates that have been tested in observational investigations and clinical trials. Large cohort studies have demonstrated that high BP is an important risk factor for heart failure, atrial fibrillation, chronic kidney disease, heart valve diseases, aortic syndromes, and dementia, in addition to coronary heart disease and stroke. In multivariate modeling, the presumed attributable risk of high BP for stroke and coronary heart disease has increased steadily with progressive use of lower values for normal BP. Meta-analysis of BP-lowering randomized controlled trials has demonstrated a benefit which is almost identical to that predicted from BP risk relationships in cohort studies. Prevention of age-related increases in BP would, in large part, reduce the vascular consequences usually attributed to aging, and together with intensive treatment of established hypertension would eliminate a large proportion of the population burden of BP-related CVD.

Blood Pressure and Hypertension StudiesHeart Rate Variability and Autonomic ControlCardiovascular Health and Disease PreventionMedicineStroke (engine)Internal medicineBlood pressureCardiologyRisk factorPopulationAtrial fibrillationCohortDisease

MeSH terms

AgingCardiovascular DiseasesHumansHypertensionPreventive Health ServicesPublic HealthRisk FactorsCausality
Citations
1,829
FWCI
65.52
field-weighted impact
References
68
Percentile
100%
vs. same field & year
Citations per year
References
The principles and practice of medicine
The American Journal of Surgery · 1938 · 1,669 citations
SOME DIFFERENT TYPES OF ESSENTIAL HYPERTENSION: THEIR COURSE AND PROGNOSIS
The American Journal of the Medical Sciences · 1974 · 814 citations
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
New England Journal of Medicine · 2015 · 11,756 citations
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
New England Journal of Medicine · 2019 · 6,600 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

High Blood Pressure and Cardiovascular Disease · Scinovex